Back to Business

Entrada Therapeutics R&D president sells $398,809 in shares

Business May 4, 2026 at 11:28 PM

Entrada Therapeutics R&D president sells $398,809 in shares

Investing.com

Read at Investing.com

More Stories

Met Gala 2026 live updates: Blake Lively, Beyoncé, and more arrive on the red carpet for fashion's biggest night

Met Gala 2026 live updates: Blake Lively, Beyoncé, and more arrive on the red carpet for fashion's b…

Beyoncé attends the 2026 Met Gala. Theo Wargo/FilmMagic All across Manhattan, stars are powdering their noses, smoothing…

🇺🇸 Business Insider 20m ago

AI’s Hottest Private Companies Have Booming Crypto Shadow Market

AI’s Hottest Private Companies Have Booming Crypto Shadow Market

The race to sell retail investors a piece of the AI boom has gone mainstream — closed-end funds, interval funds, special…

🇺🇸 Bloomberg Markets 37m ago

Secret Service Involved In Another Shooting Near White House—Just 9 Days After Correspondents’ Dinner

Secret Service Involved In Another Shooting Near White House—Just 9 Days After Correspondents’ Dinne…

One juvenile bystander was hit during the exchange of gunfire, authorities said.

🇺🇸 Forbes Business 39m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play